Standard & Poor's
http://www2.standardandpoors.comStandard & Poor’s, a division of McGraw-Hill (NYSE: MHP), produces financial research and analysis on stocks and bonds. It provides credit ratings on public and private corporations and is designated as a Nationally Recognized Statistical Rating Organization (NRSRO) by the SEC. The firm’s long-term credit ratings range from “AAA” to “D” and its short-term credit ratings range from “A-1” to “D”. Standard & Poor’s also publishes indexes including the S&P 500.
View Older Stories
-
Midday movers: Ford, Fortinet rise; Snap slumps
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Earnings season continues
-
Amgen & Eli Lilly upgraded to Overweight at Wells Fargo, Merck downgraded to Equal Weight
-
Soros buys Horizon Therapeutics, First Horizon, adds to Alphabet, cuts Amazon
-
S&P Cuts Amgen (AMGN) Rating to BBB+ from A-, Outlook Negative
-
Goldman Sachs Starts Amgen (AMGN) at Buy
-
Pre-Open Stock Movers 04/28: (ADMA) (G) (GOOGL) Higher; (PLX) (PINS) (RRD) Lower (more...)
-
Salesforce.com (CRM), Amgen (AMGN) and Honeywell International (HON) Set to Join Dow Jones Industrial Average (XOM) (PFE) (RTX)
-
S&P 500 Q2 Stock Buybacks Fall 20.1% Sequentially, 13.7% YoY
-
Goldman Sachs Downgrades Amgen (AMGN) to Buy
-
Maverick's 13F Shows New Stakes in Microsoft (MSFT), T-Mobile (TMUS), Increase in Envision (EVHC) (More)
-
S&P ekes out record on healthcare gains, tax plan hopes
-
Maverick Capital's 13F Shows New Stakes in Dow (DOW), MGM (MGM), Molson (TAP) (more...)
-
Pharma, Biotech Stocks Surge as Trump's Draft Order on Drug Prices Seen as Favorable (IBB) (XBI)
-
Maverick's 13F Shows New Stakes in Envision (EVHC), Walgreens (WBA), Increase in Inbev (BUD), Tesoro (TSO) (More...)
-
Maverick Capital Enters Martin Marietta (MLM), Raises Adobe (ADBE), Raises Aetna (AET) (more...) - 13F
-
Pre-Open Stock Movers 01/04: (EVOK) (CBAY) (OCUL) Higher; (AGRX) (ACUR) (ENSG) Lower (more...)
-
After-Hours Stock Movers 01/03: (CBAY) (SHAK) (CC) Higher; (AGRX) (ACUR) (TSLA) Lower (more...)
-
Maverick Capital 13F Shows New Stakes in Blue Buffalo Pet (BUFF), Dollar General (DG), Increase in ABI (BUD), Philip Morris (PM), (More...)
-
Loeb's Third Point LLC 13F Shows New Stakes Facebook (FB), Activision Blizzard (ATVI), Whiting (WLL) (More...)
-
Biotech, Pharma Stocks Surge as IPAB Not Triggered
-
S&P 500 slides below closely watched threshold
-
Market Wrap: Markets Slip on China Concerns; ISM Manufacturing Lagged in Dec.; GM Makes Ride-Share Investment
-
U.S. biotech bloodbath hits hedge funds but some bargains emerge
-
Buyers Seem Like Deer-in-Headlights: RBC Capital; Analyst Comments on Biotech Rout
-
Market Wrap: CPI Falls for First Time in Months on Lower Oil; Big Beer Deal in the Works; FedEx Hit on Lowered Outlook
-
UBS Upgrades Amgen (AMGN) to Buy; Cites Upside to PCSK9 Numbers
-
Streetinsider.com's Hot Lunchtime Reads 7/31: (MCD) (AMGN) (TMUS) (ATEN)
-
Loeb's Third Point Cuts Amgen (AMGN), eBay (EBAY), Adds to Delta (DAL), Actavis (ACT) Stakes
-
Market Wrap: Teva Makes it Official with Mylan; DuPont Warns on FX Impact; Yahoo!'s Display Revenue Struggle Continues
-
Market Wrap: Industrial Production Slipped in March; Europe Starts Google Probe; Nokia, Alcatel Make it Official
-
JANA Partners Enters Applied Materials (AMAT), Computer Sciences (CSC), Salix Pharmaceuticals (SLXP) (more...)
-
Loeb's Third Point Enters Citigroup (C), EMC (EMC), Philips 66 (PSX); Lifts Alibaba (BABA) (more...)
-
Market Wrap: Crude Prices Fuel Dec. Car Sales; Euro Slips to Near-Decade Lows; Fraud Hits Morgan Stanley
-
Wall Street Looks to Soothe Biotech's Holiday Meltdown (GILD) (CELG) (AMGN)
-
Celgene (CELG), Related Stocks Decline Amid Biopharma Weakness
-
Market Wrap: Defense Sec. Hagel Steps Down; Abrupt Departure for UTC CEO; Merck Acquires Ebola Vaccine Rights
-
Rosenstein's JANA Partners 13F Shows New Stakes in Advanced Micro (AMD), McDonald''s (MCD) and AECOM Technology (ACM)
-
Market Wrap: Durable Orders Slip in Sept.; Facebook Fades on Results; FTC Targets AT&T
-
Market Wrap: Existing Sales Outpace in Sept.; Loeb's Third Point Eyes Amgen; Daimler Exits Tesla; Earnings Galore
-
BofA/Merrill Lynch Sees New Era in Biotech Investing; Reinstates Coverage on 7 Large-Cap Names
-
Market Wrap: Revised Q2 GDP Ramps Higher; Telecom Italia Makes Run at Vivendi's GVT; Apple Affirms Sept. Event
-
Market Wrap: Home Prices Gain at Slower Pace; Twitter Soars in Q2; Ford Opts for Apple
-
Market Wrap: CPI Flattens in Nov.; Microsoft Undecided on CEO...for Now; Homebuilders Gain Confidence
-
Apple (AAPL), IBM (IBM), CBS (CBS) Among Top 24 Stocks for 2014 - Deutsche Bank
-
Market Wrap: Jobs Report Shows Light Adds in Sept.; Icahn Halves Netflix Stake; Apple's New iPads
-
Market Wrap: Kerry Gets Tough on Syria; Amgen, Onyx Saga Ends; Durable Orders Drop
-
Market Wrap: Sony Snubs Loeb; Kors Back in Fashion; Amgen Sweetens Onyx Offer
-
Market Wrap: Confidence Slips from Multi-Year Highs; Facebook Pushes Games; Mergers in Health-Ville
-
Streetinsider.com's Hot Lunchtime Reads 07/22: (GLD) (SKS) (YHOO) (MAN) (ONXX)

